Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
RXST 
Rxsight Inc (RXST)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/18/2025: RXST (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
11 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $10.33
1 Year Target Price $10.33
| 4 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 268.81% | Avg. Invested days 51 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 12/18/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 518.07M USD | Price to earnings Ratio - | 1Y Target Price 10.33 |
Price to earnings Ratio - | 1Y Target Price 10.33 | ||
Volume (30-day avg) 11 | Beta 1.13 | 52 Weeks Range 6.32 - 37.13 | Updated Date 12/18/2025 |
52 Weeks Range 6.32 - 37.13 | Updated Date 12/18/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.88 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -25.15% | Operating Margin (TTM) -40.14% |
Management Effectiveness
Return on Assets (TTM) -9.19% | Return on Equity (TTM) -12.92% |
Valuation
Trailing PE - | Forward PE 116.28 | Enterprise Value 302529830 | Price to Sales(TTM) 3.65 |
Enterprise Value 302529830 | Price to Sales(TTM) 3.65 | ||
Enterprise Value to Revenue 2.13 | Enterprise Value to EBITDA -7.7 | Shares Outstanding 41116640 | Shares Floating 36741830 |
Shares Outstanding 41116640 | Shares Floating 36741830 | ||
Percent Insiders 5.59 | Percent Institutions 81.71 |
About Rxsight Inc
Exchange NASDAQ | Headquaters Aliso Viejo, CA, United States | ||
IPO Launch date 2021-07-30 | President, CEO & Director Dr. Ronald M. Kurtz M.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 498 | Website https://www.rxsight.com |
Full time employees 498 | Website https://www.rxsight.com | ||
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.